February 1, 2022 Press release - Non-regulatory Targovax inngår forskningssamarbeid med Karolinska Institutet (Norwegian)
January 21, 2019 Press release - Non-regulatory Targovax is invited to present at upcoming investor conferences
December 12, 2018 Press release - Regulatory Targovax Presents at DNB 9th Annual Nordic Healthcare Conference
September 12, 2018 Press release - Regulatory Targovax announces publication of new oncolytic virus data in the Journal of Medical Virology and Cancer Gene Therapy
September 4, 2018 Press release - Regulatory Targovax ASA: Registration of new share capital following settlement of restricted stock units
August 29, 2018 Press release - Regulatory Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital
August 15, 2018 Press release - Regulatory Targovax ASA: Invitation to second quarter and first half year 2018 results presentation Thursday 23 August
June 20, 2018 Press release - Regulatory Targovax ASA: Mandatory notification of trade – primary insider
June 4, 2018 Press release - Regulatory Targovax to Present at Jefferies 2018 Global Healthcare Conference
May 16, 2018 Press release - Regulatory Targovax to present at upcoming investor and industry conferences
April 25, 2018 Press release - Regulatory Targovax ASA: Issuance of restricted stock units (RSUs) to the board members
April 25, 2018 Press release - Non-regulatory Targovax presentation at ChinaBio Partnering Forum 2018
April 24, 2018 Press release - Regulatory Targovax ASA: Invitation to first quarter 2018 results presentation Thursday 3 May
March 24, 2018 Press release - Regulatory Targovax ASA: Proposal from the nomination committee to the annual general meeting 11 April 2018
March 1, 2018 Press release - Regulatory Targovax ASA: Issuance of restricted stock unites (RSUs) to the chairman of the board of directors
February 6, 2018 Press release - Regulatory Targovax ASA: Invitation to fourth quarter and full year 2017 results presentation Thursday 15 February
November 3, 2017 Press release - Regulatory Targovax ASA: Exercise of employee share options and restricted stock units in Targovax ASA
October 27, 2017 Press release - Regulatory Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
October 24, 2017 Press release - Regulatory Targovax ASA: Invitation to third quarter 2017 results presentation Thursday 2 November
September 12, 2017 Press release - Regulatory Targovax announces start of patient recruitment in phase I/II study with ONCOS-102 in combination with durvalumab in patients with advanced peritoneal malignancies
September 11, 2017 Press release - Non-regulatory Targovax ASA: Three posters presented at ESMO conference
August 29, 2017 Press release - Regulatory Targovax ASA: Registration of share capital increase following exercise of employee options and settlement of restricted stock units
August 28, 2017 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs
August 25, 2017 Press release - Regulatory Exercise of employee share options and restricted stock units in Targovax ASA
August 23, 2017 Press release - Non-regulatory Targovax ASA: Abstracts accepted for poster presentation at the ESMO 2017 Congress
August 18, 2017 Press release - Regulatory Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
August 14, 2017 Press release - Regulatory Targovax ASA: Invitation to second quarter and first half 2017 results presentation Thursday 24 August
July 14, 2017 Press release - Regulatory Targovax ASA: Last day of the subscription period in the subsequent offering
July 6, 2017 Press release - Regulatory Targovax ASA: Registration of share capital increase following the private placement
July 3, 2017 Press release - Regulatory Targovax ASA: Commencement of subscription period for the subsequent offering
June 30, 2017 Press release - Regulatory Targovax ASA: Approval and publication of prospectus; the subsequent offering
June 30, 2017 Press release - Regulatory Targovax ASA: Extraordinary general meeting held, approval of private placement and subsequent offering
June 26, 2017 Press release - Regulatory Targovax ASA: Registration of capital increase following exercise of employee options and settlement of restricted stock units
June 22, 2017 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in relation to exercise of employee options
June 22, 2017 Press release - Regulatory Targovax ASA: Exercise of employee share options and settlement of restricted stock units in Targovax ASA
June 15, 2017 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of vested restricted stock units
June 14, 2017 Press release - Regulatory Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
June 9, 2017 Press release - Regulatory Targovax ASA – Information on the subsequent offering – Key date information
June 6, 2017 Press release - Regulatory Targovax announces formal agenda for 2017 Capital Markets Updates in Oslo and London
May 8, 2017 Press release - Regulatory Targovax ASA: Capital Markets Updates in Oslo on Thursday 8 June and in London on Monday 26 June 2017
April 28, 2017 Press release - Regulatory Targovax ASA: Issuance of restricted stock unites (RSUs) to the board members
April 19, 2017 Press release - Regulatory Targovax ASA: Invitation to first quarter 2017 results presentation Tuesday 25 April
April 4, 2017 Press release - Regulatory Targovax ASA: Proposal from the nomination committee to the annual general meeting 5 April 2017
February 24, 2017 Press release - Regulatory Targovax ASA: Registration of share capital increase following exercise of employee options and settlement of restricted stock units
February 24, 2017 Press release - Regulatory Targovax ASA: Exercise of employee share options and restricted stock units in Targovax ASA
February 13, 2017 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of restricted stock units
February 10, 2017 Press release - Regulatory Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
February 6, 2017 Press release - Regulatory Targovax ASA: Invitation to fourth quarter and full year 2016 results presentation Thursday 16 February
November 21, 2016 Press release - Regulatory Targovax ASA: Registration of share capital increase following exercise of employee options
November 21, 2016 Press release - Regulatory Targovax ASA: Exercise of employee share options in Targovax ASA
November 18, 2016 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider
November 8, 2016 Press release - Regulatory Targovax ASA: Invitation to third quarter 2016 results presentation Thursday 17 November
November 4, 2016 Press release - Regulatory Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
October 17, 2016 Press release - Non-regulatory Targovax to Present at the ESGCT/ISSCR Stem Cells & Gene Therapy Symposium
September 19, 2016 Press release - Non-regulatory Targovax to present at Redeye’s Fight Cancer conference
August 17, 2016 Press release - Non-regulatory Targovax ASA: Completion of subsequent offering, registration of share capital increase
August 17, 2016 Press release - Non-regulatory Targovax ASA: Completion of subsequent offering, registration of share capital increase
August 15, 2016 Press release - Regulatory Targovax ASA: Invitation to second quarter 2016 results presentation Thursday 25 August
August 9, 2016 Press release - Non-regulatory Targovax ASA: Allocations to primary insiders in the subsequent offering
August 9, 2016 Press release - Non-regulatory Targovax ASA: Allocations to primary insiders in the subsequent offering
August 8, 2016 Press release - Non-regulatory Targovax ASA – Last day of the subscription period in the subsequent offering
August 8, 2016 Press release - Non-regulatory Targovax ASA – Last day of the subscription period in the subsequent offering
August 4, 2016 Press release - Non-regulatory Targovax ASA – The subscription period in the subsequent offering expires on Monday 8 August at 16:30 CET
August 4, 2016 Press release - Non-regulatory Targovax ASA – The subscription period in the subsequent offering expires on Monday 8 August at 16:30 CET
July 11, 2016 Press release - Non-regulatory Targovax ASA: Commencement of subscription period for the subsequent offering
July 8, 2016 Press release - Non-regulatory Targovax ASA: Publication of prospectus, listing on Oslo Axess and subsequent offering
July 7, 2016 Press release - Non-regulatory Targovax ASA: Completion of private placement, registration of share capital increase
July 6, 2016 Press release - Non-regulatory Targovax ASA: Extraordinary general meeting held, approval of private placement and subsequent offering
July 1, 2016 Press release - Non-regulatory Targovax recruits the first patient in a trial with the oncolytic virus ONCOS-102 in malignant pleural mesothelioma
July 1, 2016 Press release - Regulatory Targovax recruits the first patient in a trial with the oncolytic virus ONCOS-102 in malignant pleural mesothelioma
June 22, 2016 Press release - Non-regulatory Targovax ASA: Announcement of successful NOK 110 million private placement
June 21, 2016 Press release - Non-regulatory Targovax ASA: Update on bookbuilding for the private placement of NOK 100 – 130 million
June 20, 2016 Press release - Non-regulatory Targovax ASA: Contemplated private placement of NOK 100 – 130 million
June 9, 2016 Press release - Regulatory Targovax receives regulatory approval in Spain to conduct a clinical trial with its oncolytic virus ONCOS-102
June 7, 2016 Press release - Regulatory Targovax ASA: Patient recruitment for TG01 immuno-oncology trial completed
June 2, 2016 Press release - Regulatory Targovax receives approval in Australia to conduct a clinical trial with TG02 – an immunotheraphy treatment targeting RAS mutations
May 20, 2016 Press release - Non-regulatory Magnus Jaderberg, CMO of Targovax, has presented at a symposium by The Royal Swedish Academy of Engineering Sciences
May 9, 2016 Press release - Regulatory Targovax to present at BioEquity Europe and its first quarter 2016 results on May 11 – 12, 2016
May 9, 2016 Press release - Non-regulatory Targovax ASA: Registration of share capital increase following exercise of employee options
April 15, 2016 Press release - Non-regulatory Targovax ASA: Grant of restricted stock units to the Board of directors
April 14, 2016 Press release - Regulatory Targovax reports immune response with reduced number of TG01 vaccinations
April 14, 2016 Press release - Non-regulatory Resolution to increase the share capital in Targovax ASA in relation to exercise of employee options
March 15, 2016 Press release - Non-regulatory Targovax to present at forthcoming Life Science and Investor conferences
March 14, 2016 Press release - Regulatory Targovax to present at forthcoming Life Science and Investor conferences
March 10, 2016 Press release - Regulatory Targovax announces encouraging interim results with RAS specific peptide vaccine in resected pancreatic cancer
February 25, 2016 Press release - Regulatory CORRECTION: Targovax ASA: Invitation to Fourth Quarter 2015 Results Presentation
February 25, 2016 Press release - Regulatory Targovax ASA: Invitation to Fourth Quarter 2015 Results Presentation
February 2, 2016 Press release - Regulatory Targovax submits a study of its adenovirus based immune therapy ONCOS-102 to the regulatory authorities in Spain
December 14, 2015 Press release - Non-regulatory DNB’s 6th Annual Health Care Conference, Oslo, 15 December 2015
November 19, 2015 Press release - Regulatory Targovax ASA: Invitation to presentation of Targovax’ third quarter 2015 results
November 18, 2015 Press release - Regulatory Targovax ASA: LUDWIG CANCER RESEARCH AND CANCER RESEARCH INSTITUTE PARTNER WITH TARGOVAX TO TEST CANDIDATE VIROTHERAPY IN EARLY-PHASE CLINICAL TRIALS
November 5, 2015 Press release - Regulatory Targovax ASA: Immunotherapy with ONCOS-102 show potential to activate immunologically silent tumors and reduce local immune suppression in advanced tumors
July 2, 2015 Press release - Non-regulatory Targovax AS: Closing of the acquisition of Oncos Therapeutics Oy
June 18, 2015 Press release - Non-regulatory Targovax announces successful NOK 200 million private placement
June 15, 2015 Press release - Non-regulatory Targovax increases size of private placement to NOK 200 million after strong investor demand
June 11, 2015 Press release - Non-regulatory Targovax and Oncos Therapeutics join forces to create a Nordic leader within immuno-oncology
June 1, 2015 Press release - Non-regulatory Targovax presented safety data and immunological results at the 2015 ASCO Annual Meeting
April 20, 2015 Press release - Non-regulatory Targovax ASA: Oncos Therapeutics presenting at the Anglonordic Life Science Conference on April 23rd in London, UK.
April 13, 2015 Press release - Non-regulatory Targovax has appointed Peter Skorpil as Head of Business Development, effective from April 8th, 2015.
March 9, 2015 Press release - Non-regulatory Targovax has decided to expand the on-going phase I/II clinical study CT-TG01-01 with a new group of up to 13 patients.
February 26, 2015 Press release - Non-regulatory Targovax ASA: Oncos represented at the 8th Annual Life Science CEO Forum & Exhibition March 3rd, 2015 in Zurich, Switzerland
February 26, 2015 Press release - Non-regulatory Targovax is pleased to announce Mr. Øystein Soug as the new CFO of the Company from June 1, 2015
January 26, 2015 Press release - Non-regulatory Targovax ASA: ONCOS-102 Mechanism of Action -video released on the website
January 12, 2015 Press release - Non-regulatory Targovax ASA: ONCOS-102 granted US lung cancer orphan drug designation
January 8, 2015 Press release - Non-regulatory Targovax reports completion of recruitment of patients in the phase I/II clinical trial CT TG01-01
December 17, 2014 Press release - Non-regulatory Targovax ASA: “ONCOS-102 sensitizes tumors to other immunotherapies” – Paper published in the latest issue of OncoImmunology
November 25, 2014 Press release - Non-regulatory Targovax ASA: Oncos Therapeutics receives a positive opinion on orphan drug designation for ONCOS-102
November 20, 2014 Press release - Non-regulatory Targovax ASA: Oncos presented a poster at EORTC-NCI-AACR Meeting 2014
November 10, 2014 Press release - Non-regulatory Targovax ASA: Oncos presented a poster at the SITC Annual Meeting 2014
November 5, 2014 Press release - Non-regulatory Targovax ASA: Sari Pesonen invited to present a poster at EORTC-NCI-AACR 2014, Nov 18-21, in Barcelona
November 5, 2014 Press release - Non-regulatory Targovax ASA: Frans Wuite invited to be a panelist in European Business Angel on Nov 17
November 5, 2014 Press release - Non-regulatory MEET US: DNB Markets Health Care Conference 2014, December 11th 2014, Oslo, Norway
November 3, 2014 Press release - Non-regulatory Targovax AS has reached primary endpoint for the ongoing phase I/II clinical trial CT TG01-01
October 30, 2014 Press release - Non-regulatory Targovax ASA: Frans Wuite presenting Oncos at Bio Europe 2014 on Nov 5, 2014 in Frankfurt
October 27, 2014 Press release - Non-regulatory Targovax ASA: Oncos presenting at the fall seminar of Statisticians in Finnish Pharmaceutical Industry held in Turku, Finland Oct 30, 2014
October 1, 2014 Press release - Non-regulatory Targovax Presentation Arctic Biotech Day September 2014
June 4, 2014 Press release - Non-regulatory Targovax ASA: Oncos Therapeutics recruits Dr Magnus Jaderberg as CMO to strengthen its focus on cancer immunotherapy
June 2, 2014 Press release - Non-regulatory Oncos Therapeutics granted US and EU Orphan Drug Designation for ONCOS-102 in ovarian cancer
May 8, 2014 Press release - Non-regulatory Targovax ASA: ONCOS – achievement in cancer immunotherapy – PRESS RELEASE
February 28, 2014 Press release - Non-regulatory Targovax ASA: ATMP classification for ONCOS-102 by European Medicines Agency
February 6, 2014 Press release - Non-regulatory Targovax TG01 immunotherapy reaches phase IIA in operable pancreatic cancer
January 31, 2014 Press release - Non-regulatory Targovax ASA: Oncos Therapeutics among Top 20 Finnish startup companies by Talouselämä journal
October 15, 2013 Press release - Non-regulatory Oncos Therapeutics nominated the Nordic Star Finland by SwedenBIO
September 15, 2013 Press release - Non-regulatory Professor Hani Gabra joins Clinical Advisory Board of Oncos Therapeutics
July 31, 2013 Press release - Non-regulatory Oncos Therapeutics granted Orphan Drug Designation for CGTG-102 by FDA and EMA
June 21, 2013 Press release - Non-regulatory Oncos Therapeutics nominated again among the most promising startup companies
January 29, 2013 Press release - Non-regulatory First patient included in phase I/II clinical study with TG01 in operable pancreatic cancer
November 14, 2012 Press release - Non-regulatory Oncos Therapeutics appoints experienced industry leader Frans Wuite as President and CEO
May 29, 2012 Press release - Non-regulatory Oncos Therapeutics successfully initiates Phase I clinical study
March 14, 2012 Press release - Non-regulatory Patient recruitment started in C1 study in Finland (in Finnish)
January 25, 2012 Press release - Non-regulatory Secures 13 MNOK for development of pancreas cancer vaccine TG01
